Literature DB >> 23234452

Primary ciliary dyskinesia: recent advances in epidemiology, diagnosis, management and relationship with the expanding spectrum of ciliopathy.

Andrew Bush1, Claire Hogg.   

Abstract

Human cilia were once thought merely to be important in respiratory mucociliary clearance, with primary ciliary dyskinesia (PCD) the sole manifestation of ciliary dysfunction. There are now known to be three types of cilia: primary, nodal and motile. Cilia are complex, likely involving more than 1000 gene products; in this review, recent advances in PCD genetics, and the potential relationships with genes causing other ciliopathies, are discussed. PCD is the most important respiratory disease, characterized by upper and lower airway infection and inflammation and disorders of laterality. Ciliary gene mutations are now known to cause single organ disease, as well as complex syndromes. The focus of the review is primarily PCD, in the context of the expanding ciliopathy spectrum. The authors consider the clinical situations in which ciliary disease should be considered, and the implications for specialist respiratory practice.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23234452     DOI: 10.1586/ers.12.60

Source DB:  PubMed          Journal:  Expert Rev Respir Med        ISSN: 1747-6348            Impact factor:   3.772


  21 in total

1.  Continuous mucociliary transport by primary human airway epithelial cells in vitro.

Authors:  Patrick R Sears; Wei-Ning Yin; Lawrence E Ostrowski
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-05-15       Impact factor: 5.464

Review 2.  RhoGTPase-binding proteins, the exocyst complex and polarized vesicle trafficking.

Authors:  Debarati Mukherjee; Arpita Sen; R Claudio Aguilar
Journal:  Small GTPases       Date:  2014-06-10

3.  Airway Epithelial KIF3A Regulates Th2 Responses to Aeroallergens.

Authors:  Premkumar Vummidi Giridhar; Sheila M Bell; Anusha Sridharan; Priya Rajavelu; Joseph A Kitzmiller; Cheng-Lun Na; Matthew Kofron; Eric B Brandt; Mark Ericksen; Anjaparavanda P Naren; Changsuk Moon; Gurjit K Khurana Hershey; Jeffrey A Whitsett
Journal:  J Immunol       Date:  2016-10-28       Impact factor: 5.422

4.  Reduced mucociliary clearance in old mice is associated with a decrease in Muc5b mucin.

Authors:  Barbara R Grubb; Alessandra Livraghi-Butrico; Troy D Rogers; Weining Yin; Brian Button; Lawrence E Ostrowski
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-03-11       Impact factor: 5.464

Review 5.  Rare Lung Diseases: Congenital Malformations.

Authors:  Andrew Bush
Journal:  Indian J Pediatr       Date:  2015-06-23       Impact factor: 1.967

6.  Laterality defects other than situs inversus totalis in primary ciliary dyskinesia: insights into situs ambiguus and heterotaxy.

Authors:  Adam J Shapiro; Stephanie D Davis; Thomas Ferkol; Sharon D Dell; Margaret Rosenfeld; Kenneth N Olivier; Scott D Sagel; Carlos Milla; Maimoona A Zariwala; Whitney Wolf; Johnny L Carson; Milan J Hazucha; Kimberlie Burns; Blair Robinson; Michael R Knowles; Margaret W Leigh
Journal:  Chest       Date:  2014-11       Impact factor: 9.410

Review 7.  Smelling the roses and seeing the light: gene therapy for ciliopathies.

Authors:  Jeremy C McIntyre; Corey L Williams; Jeffrey R Martens
Journal:  Trends Biotechnol       Date:  2013-04-17       Impact factor: 19.536

8.  Airway ciliary dysfunction: Association with adverse postoperative outcomes in nonheterotaxy congenital heart disease patients.

Authors:  Eileen Stewart; Phillip S Adams; Xin Tian; Omar Khalifa; Peter Wearden; Maliha Zahid; Cecilia W Lo
Journal:  J Thorac Cardiovasc Surg       Date:  2017-09-20       Impact factor: 5.209

Review 9.  Diagnosis of primary ciliary dyskinesia.

Authors:  Mary Anne Kowal Olm; Elia Garcia Caldini; Thais Mauad
Journal:  J Bras Pneumol       Date:  2015 May-Jun       Impact factor: 2.624

10.  Lung Clearance Index (LCI) is Stable in Most Primary Ciliary Dyskinesia (PCD) Patients Managed in a Specialist Centre: a Pilot Study.

Authors:  S Irving; S Carr; C Hogg; M Loebinger; A Shoemark; A Bush
Journal:  Lung       Date:  2017-06-20       Impact factor: 2.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.